Navigation Links
Simbionix and AABIP Sign Collaboration Agreement
Date:11/2/2010

Simbionix and AABIP Sign Collaboration Agreement -- CLEVELAND, November 2, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Education, Contracts, Joint Ventures, New Products & Services Click to view news release full screen  

Simbionix and AABIP Sign Collaboration Agreement

 

CLEVELAND, November 2, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation technology, is pleased to announce they have signed a collaboration agreement with the American Association for Bronchology and Interventional Pulmonology (AABIP) on the development of a Bronchoscopic Essential Skills module.

Simbionix new Bronchoscopy essential skills module is being developed in conjunction with, and endorsed by the AABIP. The new module offers designated skill tasks covering the spectrum of Bronchoscopic skills required. This module is intended to provide the trainee with solid habits for safe and efficient performance, and to enhance hand-eye coordination, 3D perception and anatomical knowledge.

Gerard Silvestri, AABIP President, said that "The daily practice of clinicians is highly affected by the progression of medical technologies, as they are required to adapt to fast changes and developments. It is therefore essential to develop new training programs that utilize the advanced technologies, such as virtual reality simulators, to assure that the educational curriculum is entirely covered. We chose to work with simbionix since we believe that only close collaboration between the medical community and companies that provide cutting edge technologies are essential to successfuly design these programs for the benefit of the physicians, the patients and the entire medical field."

"We are very excited to have reached yet another collaboration agreement with a leading medical society" commented Mr. Ran Bronstein, Simbionix President. "All of our products are designed with the cooperation of the medical community, who play an active role in simulation design, content definition, and product testing and validation. Simbionix continuously provides the procedural and technological know-how and actively joins forces with the leading medical associations and the medical industry to optimize training solutions and to advance clinical performance."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com

About the American Association for Bronchology and Interventional Pulmonology

AABIP is dedicated to promoting excellence in clinical care, education, and research in the rapidly expanding fields of Bronchoscopy, Interventional Pulmonology, and Interventional Bronchoscopy.

For more information on the AABIP, visit http://www.aabronchology.org Contact: Rebecca Zitter Manager of Marketing Communications and Distributor Relations rebecca@simbionix.com +1-216-2292040
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
4. Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
7. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
8. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
9. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
10. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
11. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research ... Health Market Analysis & Trends - Industry Forecast to 2025" ... ... at a CAGR of around 23.8% over the next decade to ... analyzes the market estimates and forecasts for all the given segments ...
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies ... eye market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Dry eye ...
(Date:2/24/2017)... 2017 Juan Monteverde , founder and ... a boutique securities firm headquartered at the Empire State ... announces that a class action lawsuit has been filed in ...  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or the "Company") ... 23, 2015 and December 30, 2016, inclusive (the "Class ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... ... again hosted their Military Wedding Giveaway, with the winning couple announced on Feb. ... with services generously donated from local vendors: A Matter of Taste, Ryan Rousseau ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, 2017 ... letter to withdraw previous guidance issued by the Obama Administration requiring schools ... in May 2016 by the Obama Administration came in response to a growing ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) ... Meeting. KLS is a longtime supporter of the event. , "We are pleased ... Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track ...
(Date:2/23/2017)... ... ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North Hollywood ... of February, patients who visit Hamlin Dental Group will receive a ticket for a ... the Cheesecake Factory. , Tickets are available for routine dental visits and other ...
Breaking Medicine News(10 mins):